Abstract
In our model of the COVID-19 epidemic, infected individuals can be of four types, according whether they are asymptomatic (A) or symptomatic (I), and use a contact tracing mobile phone app (Y) or not (N). We denote by f the fraction of A’s, by y the fraction of Y’s and by R0 the average number of secondary infections from a random infected individual.
We investigate the effect of non-electronic interventions (voluntary isolation upon symptom onset, quarantining private contacts) and of electronic interventions (contact tracing thanks to the app), depending on the willingness to quarantine, parameterized by four cooperating probabilities.
For a given ‘effective’ R0 obtained with non-electronic interventions, we use nonnegative matrix theory and stopping line techniques to characterize mathematically the minimal fraction y0 of app users needed to curb the epidemic. We show that under a wide range of scenarios, the threshold y0 as a function of R0 rises steeply from 0 at R0 = 1 to prohibitively large values (of the order of 60 – 70% up) whenever R0 is above 1.3. Our results show that moderate rates of adoption of a contact tracing app can reduce R0 but are by no means sufficient to reduce it below 1 unless it is already very close to 1 thanks to non-electronic interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author was entirely funded by his hosting institution, the Center for Interdisciplinary Research in Biology (CNRS, Collège de France, Paris)
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No data
